Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
39.65
+0.67 (1.72%)
At close: May 31, 2024, 3:59 PM
39.97
+0.32 (0.81%)
After-hours: May 31, 2024, 6:56 PM EDT
CALT Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CALT stock have an average target of 37.5, with a low estimate of 18 and a high estimate of 50. The average target predicts a decrease of -5.42% from the current stock price of 39.65.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CALT stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $39 | Strong Buy → Hold | Downgrades | $39 | -1.64% | May 31, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $58 → $39 | Strong Buy → Hold | Downgrades | $58 → $39 | -1.64% | May 28, 2024 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $55 → $40 | Strong Buy → Hold | Downgrades | $55 → $40 | +0.88% | May 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $39 | Strong Buy → Hold | Downgrades | $39 | -1.64% | May 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +13.49% | May 24, 2024 |
Financial Forecast
Revenue This Year
2.00B
from 1.21B
Increased by 65.88%
Revenue Next Year
3.38B
from 2.00B
Increased by 68.63%
EPS This Year
2.45
from -17.38
EPS Next Year
17.22
from 2.45
Increased by 602.97%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.5B | 4.6B | 6.9B | 10.2B | 13.0B |
| Avg | 2.0B | 3.4B | 4.8B | 7.0B | 7.7B |
| Low | 1.8B | 2.4B | 2.9B | 3.8B | 3.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 107.6% | 128.3% | 103.2% | 109.8% | 85.3% |
| Avg | 65.9% | 68.6% | 43.6% | 45.2% | 9.7% |
| Low | 47.2% | 18.2% | -14.0% | -21.7% | -44.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.56 | 34.34 | 66.15 | 111.91 | 153.15 |
| Avg | 2.45 | 17.22 | 34.47 | 109.78 | 150.23 |
| Low | -0.80 | 9.15 | 16.51 | 104.45 | 142.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,301.8% | 284.2% | 224.6% | 39.5% |
| Avg | - | 603.0% | 100.2% | 218.4% | 36.9% |
| Low | - | 273.7% | -4.1% | 203.0% | 30.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.